JB Capital Partners LP Takes Position in Varex Imaging $VREX

JB Capital Partners LP acquired a new position in Varex Imaging (NASDAQ:VREX) during the second quarter, according to its most recent disclosure with the Securities & Exchange Commission. The fund acquired 338,964 shares of the company’s stock, valued at approximately $3,535,395,000. Varex Imaging accounts for about 0.5% of JB Capital Partners LP’s portfolio, making the stock its 24th biggest position.

A number of other hedge funds and other institutional investors also recently made changes to their positions in VREX. Pzena Investment Management LLC bought a new stake in Varex Imaging in the second quarter valued at approximately $45,312,000. BlackRock Inc. acquired a new position in shares of Varex Imaging in the 2nd quarter worth approximately $40,624,000. Deutsche Bank AG acquired a new position in shares of Varex Imaging in the 2nd quarter worth approximately $432,000. Rice Hall James & Associates LLC bought a new stake in shares of Varex Imaging in the 2nd quarter valued at $15,080,000. Finally, Bank of New York Mellon Corp bought a new stake in shares of Varex Imaging in the 2nd quarter valued at $1,671,000.

Analysts Set New Price Targets

VREX has been the subject of a number of analyst reports. Oppenheimer downgraded shares of Varex Imaging from an “outperform” rating to a “market perform” rating in a research note on Monday, August 10th. Wall Street Zen raised shares of Varex Imaging from a “hold” rating to a “buy” rating in a research report on Saturday, July 4th. Zacks Research downgraded Varex Imaging from a “strong-buy” rating to a “hold” rating in a report on Monday, July 27th. CJS Securities lowered Varex Imaging from an “outperform” rating to a “market perform” rating in a research report on Monday, August 17th. Finally, Sidoti reissued a “neutral” rating and issued a $19.00 price objective on shares of Varex Imaging in a research note on Monday, August 10th. Six research analysts have rated the stock with a Hold rating and one has assigned a Sell rating to the company’s stock. According to MarketBeat.com, the company has an average rating of “Reduce” and an average price target of $16.88.

Varex Imaging Stock Up 0.1%

Shares of NASDAQ:VREX opened at $18.51 on Friday. The business’s 50 day simple moving average is $12.38 and its two-hundred day simple moving average is $11.84. The firm has a market cap of $779.27 million, a P/E ratio of 35.60 and a beta of 0.89. The company has a debt-to-equity ratio of 0.64, a quick ratio of 1.53 and a current ratio of 3.38. Varex Imaging has a 52-week low of $9.09 and a 52-week high of $18.63.

Varex Imaging (NASDAQ:VREX) last announced its quarterly earnings data on Monday, August 10th. The company reported $0.31 EPS for the quarter, beating analysts’ consensus estimates of $0.21 by $0.10. The firm had revenue of $210.50 million during the quarter, compared to analysts’ expectations of $215.50 million. Varex Imaging had a return on equity of 9.19% and a net margin of 2.55%. As a group, research analysts forecast that Varex Imaging will post 0.98 EPS for the current fiscal year.

About Varex Imaging

Varex Imaging Corporation is a global provider of X-ray imaging components and solutions for the medical, security and industrial markets. The company designs, develops and manufactures a broad range of products that convert X-ray energy into high-resolution digital images. Its portfolio includes X-ray tubes, flat panel detectors, digital sensors, specialty radiographic tubes and related software, all engineered to meet the demanding requirements of original equipment manufacturers (OEMs) in diagnostic imaging, computed tomography (CT), fluoroscopy, mammography, dental radiography and non-destructive testing applications.

The company’s medical imaging offerings support a wide spectrum of clinical modalities, from portable radiography systems to advanced CT scanners, enhancing image quality and dose efficiency for healthcare providers.